Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Constance Delaby und 59 weiteren Autor:innen. Beteiligte Einrichtung: Univ Montpellier, LBPC-PPC, CHU Montpellier, INSERM, Montpellier, France. Hauptthemen laut MEDLINE: Nervous System Diseases, Neurofilament Proteins. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
INTRODUCTION Neurofilament light chain (NfL) quantification aids in diagnosing and predicting neurological disorders, but clinical and laboratory practices vary across centers. Differences in result interpretation and reporting further challenge test commutability. This study aimed to review the global analytical and post‐analytical methods used for NfL measurement in routine clinical practice across different contexts. METHODS We established an international working group (WG) and distributed a survey to its members to gather information on context of use (COU), (pre) analytical methods, cutoff usage, as well as the interpretation and reporting of NfL measurements. RESULTS Among the centers, 63% measured NfL in cerebrospinal fluid (CSF), 87% in blood, and 53% in both. COU was widespread, with 50% defining pathological cutoffs based on publications and 42% considering age. Reporting was primarily done through numeric results (95%). DISCUSSION Harmonizing cutoffs, reporting, and interpretation across various clinical contexts will facilitate the incorporation of this biomarker into routine clinical practice. Highlights Unique international overview of current analytical and post‐analytical methods for neurofilament light chain (NfL) measurement in routine clinical practice. Tailored sheets for each neurological application. Strategies to harmonize cutoffs, reporting, and interpretation of NfL's measurement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Univ Montpellier, LBPC-PPC, CHU Montpellier, INSERM, Montpellier, France.
- Department of Unitat de Memoria, Hospital de la Santa Creu iSant Pau - Biomedical Research Institute Sant Pau - Universitat Autònoma de Barcelona, Barcelona, Spain.
- Clinical chemistry department, CHU de Liège, Liège, Belgium.
- Clinical analysis service, Hospital do Meixoeiro, Área Sanitaria de Vigo, Vigo, Spain.
- Center for Neurodegenerative Diseases and the Aging Brain, Department of Clinical Research in Neurology, University of Bari "A. Moro" at Pia Fondazione "Cardinale G. Panico", Tricase, Lecce, Italy.
- Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany.
ORCID-Profile: Constance Delaby
Zitieren
APA
Delaby, C., Ladang, A., Martinez-Yriarte, J., Zecca, C., Logroscino, G., Körtvelyessy, P., Tumani, H., Parchi, P., Quadrio, I., Hart, M., Olsen, D. A., Alcolea, D., Blennow, K., Fortea, J., Lleo, A., Algeciras-Schimnich, A., Ayrignac, X., Bedel, A., Santos, G. A. A., …, & Perez Garay, R. (2025). Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70343
Vancouver
Delaby C, Ladang A, Martinez-Yriarte J, Zecca C, Logroscino G, Körtvelyessy P, et al. Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70343
BibTeX
@article{Delaby2025,
author = {Delaby, Constance and Ladang, Aurélie and Martinez-Yriarte, Jose and Zecca, Chiara and Logroscino, Giancarlo and Körtvelyessy, Peter and Tumani, Hayrettin and Parchi, Piero and Quadrio, Isabelle and Hart, Melanie and Olsen, Dorte Aalund and Alcolea, Daniel and Blennow, Kaj and Fortea, Juan and Lleo, Alberto and Algeciras-Schimnich, Alicia and Ayrignac, Xavier and Bedel, Aurélie and Santos, Gustavo A A and Borelli, Wyllians and Bouaziz-Amar, Elodie and Baldeiras, Inês and Bigot-Corbel, Edith and Bjerke, Maria and Carretero Perez, Mercedes and Casoli, Tiziana and Chabrashvili, Tinatin and Chapman, Miles D and Cusato, Jessica and Dursun, Erdinc and Fourier, Anthony and Galimberti, Daniela and Gezen-Ak, Duygu and Gordon, Brian A and Gouju, Julien and de Las Heras Florez, Silvia and Hernandez Sanchez, Juanjo and Herwerth, Marina and Imperiale, Daniele and Kaczorowski, Flora and Kasuga, Kensaku and Keshavan, Ashvini and Khalil, Michael and Kuhle, Jens and Leithner, Christoph and Lewczuk, Piotr and Letournel, Franck and Tsolaki, Magda and Giuffrè, Guido Maria and Blanc, Marie-Céline and Mroczko, Barbara and Martínez Rodríguez, Jose Enrique and Musso, Giulia and Kulczynska-Przybik, Agnieszka and Nogueira, Léonor and Paquet, Claire and Baiardi, Simone and Gaetani, Lorenzo and Parnetti, Lucilla and Perez Garay, Raquel},
title = {Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70343}
}
EUVIMED